SCHEMBL30107965

SCHEMBL30107965

COc1ccc2c(c1)nnn2-c1cc(-c2cnc(C)s2)nc(Cl)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 3/20 0.40
NPSR1 Q6W5P4 1/20 0.36
PDE2A O00408 4/20 0.33
PDE10A Q9Y233 4/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
KDM4E B2RXH2 1/20 0.32
MAPT P10636 4/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
TSHR P16473 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LIMK1 P53667 2/20 0.31
LIMK2 P53671 2/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
RAB9A P51151 1/20 0.31
ATM Q13315 1/20 0.31
EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108003 0.88 MET (0.40) METNPSR1TDP1MAPTALDH1A1
SCHEMBL30107975 0.78 L3MBTL1 (0.40) PDE2APDE10AL3MBTL1TDP1KDM4E
SCHEMBL30107973 0.76 KDM4E (0.46) METTDP1KDM4EMAPTALDH1A1
SCHEMBL30107988 0.73 TSHR (0.33) L3MBTL1KDM4ETSHRSMN1; SMN2
SCHEMBL30108036 0.73 PIM1 (0.46) NPSR1PDE2APDE10AL3MBTL1TDP1
SCHEMBL30108065 0.72 TSHR (0.47) PDE10AKDM4EMAPTALDH1A1TSHR
SCHEMBL30107968 0.71 IDH1 (0.35) PDE2APDE10AL3MBTL1TDP1ALDH1A1
SCHEMBL30108027 0.69 TSHR (0.39) KDM4EALDH1A1TSHRSMN1; SMN2RAB9A
SCHEMBL30107966 0.68 TSHR (0.40) PDE2APDE10AL3MBTL1TDP1KDM4E
SCHEMBL4590708 0.66 L3MBTL1 (0.48) NPSR1L3MBTL1KDM4EMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed